In Saudi Arabia, a new case of the deadly coronavirus has been detected where 15 people have already died after contracting it, the health ministry announced on its Internet website.
"One new case of novel coronavirus recorded in the Eastern Region" where most of the kingdom's cases have been registered, said the ministry, which this week created a special web page dedicated to the outbreak.
Cell Response to Novel Human Coronavirus Opens Possible Paths to Treatments
WHAT: To study the cells' response to infection by a novel human coronavirus (called nCoV), NIH-supported scientists used lab-grown human lung cells.
Advertisement
"One case of coronavirus has been recorded in the Eastern Region, and he is now under the medical healthcare receiving the proper treatment," the web page in English reported.
The latest case takes to 31 the number of officially recorded cases of the virus in the oil-rich Gulf kingdom since September. Fifteen of those have died.
![Treatment for Coronavirus In Early Lab Tests Shows Promise]( "Treatment for Coronavirus In Early Lab Tests Shows Promise")
Scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
On Wednesday, the Geneva-based World Health Organisation reported that two Saudi health workers have contracted the deadly coronavirus from patients -- the first evidence of transmission in a hospital setting.
"This is the first time health care workers have been diagnosed with nCoV (novel coronavirus) infection after exposure to patients," the WHO said in a statement.
Since last September, the WHO says it has been informed of a global total of 40 laboratory confirmed cases of the virus, including 20 deaths.
While the virus has been deadliest in Saudi Arabia, cases have also been reported in Jordan, Qatar, Germany, Britain and France, where two patients are now in hospital in the northern city of Lille.
The virus is a cousin of Severe Acute Respiratory Syndrome (SARS), which triggered a scare 10 years ago when it erupted in east Asia, leaping to humans from animal hosts and eventually killing some 800 people.
Source: AFP
Treatment for Coronavirus In Early Lab Tests Shows Promise
Scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
Advertisement
On Wednesday, the Geneva-based World Health Organisation reported that two Saudi health workers have contracted the deadly coronavirus from patients -- the first evidence of transmission in a hospital setting.
"This is the first time health care workers have been diagnosed with nCoV (novel coronavirus) infection after exposure to patients," the WHO said in a statement.
Since last September, the WHO says it has been informed of a global total of 40 laboratory confirmed cases of the virus, including 20 deaths.
While the virus has been deadliest in Saudi Arabia, cases have also been reported in Jordan, Qatar, Germany, Britain and France, where two patients are now in hospital in the northern city of Lille.
The virus is a cousin of Severe Acute Respiratory Syndrome (SARS), which triggered a scare 10 years ago when it erupted in east Asia, leaping to humans from animal hosts and eventually killing some 800 people.
Source: AFP
To Study Novel Coronavirus Infection NIH Scientists Develop Monkey Model
A model of infection was developed in rhesus macaques by National Institutes of Health (NIH) researchers.
Advertisement
 Patient-to-nurse Infection of Coronavirus: First ProofThe World Health Organization said that two Saudi health workers have contracted the deadly coronavirus from patients, marking the first evidence of transmission in a hospital setting. | Advertisement
|
Advertisement
Recommended Reading
Latest Coronavirus News
The WHO has issued a warning to nations globally, urging them to undertake necessary preparations for an impending pandemic that could be even deadlier than the coronavirus.
In a notable discovery, US researchers have outlined 12 key symptoms linked to Long COVID, a condition characterized by persistent symptoms after a COVID-19 infection.
Partially vaccinated COVID-19 patients are at an increased risk of dying when infected with either the Omicron or Delta variant.
Recent research indicates that the decision-making abilities of college students may have been adversely impacted by the COVID-19 pandemic.
New study explores how COVID-19 lockdown policies should be varied during the year or so gap between when a vaccine is approved and when all who wish have been vaccinated.